Christopher E. Loh on Muck Rack

Christopher E. Loh

London
As seen in: Wiley Online Library, Annals of the Rheumatic Diseases, Law360, JD Supra, LexisNexis, Lexology, The Licensing Journal, IP Watchdog, Intellectual Property & Technology Law Journal, Intellectual Asset Management
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher E.

Contact Christopher E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Supreme Court Clarifies Standard for Pleading Inducement of Patent Infringement in Hikma v. Amarin

|
By Christopher E. Loh
| JD Supra
On June 4, 2026, a unanimous Supreme Court in Hikma Pharms. USA Inc. v. Amarin Pharma, Inc., No. 24-889, clarified the standard for pleading induced patent infringement under 35 U.S.C. § 271(b). Although Hikma dealt specifically with an inducement claim against a “skinny label” generic drug maker, the Hikma opinion is broadly applicable to all inducement claims.
Open in Who Shared Issue with article?

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known Antibody Genus

|
By Christopher E. Loh
| JD Supra
On April 16, 2026, a Federal Circuit panel in Teva Pharms. Int'l GmbH v. Eli Lilly & Company, No. 24-1094, held that patent claims directed to methods of treating headache using a certain genus of antibodies satisfied the written description and enablement requirements of 35 U.S.C. Section 112. In so holding, the Federal Circuit distinguished the Supreme Court's 2023 Amgen v.
Open in Who Shared Issue with article?

Assessing EcoFactor's Impact On Damages Experts' Opinions

|
By Christopher E. Loh
| Law360 Verified
By Christopher Loh ( April 14, 2026, 4:50 PM EDT) -- Last year, the U.S. Court of Appeals for the Federal Circuit, in its first en banc review of a utility patent case since 2018, addressed the admissibility of expert opinions on patent damages. As we approach the one-year anniversary of the May 21, 2025, ruling, it's a good time to assess its impact.... Law360 is on it, so you are, too.
Open in Who Shared View Duplicates (267) Issue with article?
See all 12 licensed articles (14 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified